Back to Search
DAVID METZ, MD
MD
Gastroenterology Physician
NPI: 1225042252Individual
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
MD040405L(PA)
Gastroenterology PhysicianPrimary
Internal Medicine — Gastroenterology
Code: 207RG0100X
MD040405L(PA)
Research & Publications (20)
Review article: dual delayed release formulation of dexlansoprazole MR, a novel approach to overcome the limitations of conventional single release proton pump inhibitor therapy.
PMID 19298580·Aliment Pharmacol Ther·2009
6-review
Clinical trial: dexlansoprazole MR, a proton pump inhibitor with dual delayed-release technology, effectively controls symptoms and prevents relapse in patients with healed erosive oesophagitis.
PMID 19210298·Aliment Pharmacol Ther·2009
3-trial
Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors.
PMID 18703061·Gastroenterology·2008
6-review
Greater immediate gastric acid suppression with lansoprazole 30 mg administered as a 2-minute intravenous bolus injection versus a 30-minute infusion.
PMID 18294109·Pharmacotherapy·2008
3-trial
Effects of esomeprazole on acid output in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion.
PMID 17764495·Am J Gastroenterol·2007
4-observational
Lansoprazole regimens that sustain intragastric pH > 6.0: an evaluation of intermittent oral and continuous intravenous infusion dosages.
PMID 16573801·Aliment Pharmacol Ther·2006
4-observational
Three-year oral pantoprazole administration is effective for patients with Zollinger-Ellison syndrome and other hypersecretory conditions.
PMID 16423003·Aliment Pharmacol Ther·2006
3-trial
Comparison of the effects of intravenously and orally administered esomeprazole on acid output in patients with symptoms of gastro-oesophageal reflux disease.
PMID 16225490·Aliment Pharmacol Ther·2005
4-observational
Preventing the gastrointestinal consequences of stress-related mucosal disease.
PMID 15881471·Curr Med Res Opin·2005
6-review
Managing gastroesophageal reflux disease for the lifetime of the patient: evaluating the long-term options.
PMID 15478853·Am J Med·2004
4-observational
Maintenance oral pantoprazole therapy is effective for patients with Zollinger-Ellison syndrome and idiopathic hypersecretion.
PMID 12591045·Am J Gastroenterol·2003
8-other
Pantoprazole maintenance therapy prevents relapse of erosive oesophagitis.
PMID 12492745·Aliment Pharmacol Ther·2003
3-trial
Proton pump activation in stimulated parietal cells is regulated by gastric acid secretory capacity: a human study.
PMID 12017345·J Clin Pharmacol·2002
3-trial
Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
PMID 11774936·Am J Gastroenterol·2001
8-other
A randomized controlled crossover study comparing synthetic porcine and human secretins with biologically derived porcine secretin to diagnose Zollinger-Ellison Syndrome.
PMID 11328261·Aliment Pharmacol Ther·2001
3-trial
Potential uses of intravenous proton pump inhibitors to control gastric acid secretion.
PMID 11025353·Digestion·2000
6-review
Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux disease.
PMID 10710049·Am J Gastroenterol·2000
3-trial
Stool testing for Helicobacter pylori infection: yet another noninvasive alternative.
PMID 10685767·Am J Gastroenterol·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3400 CIVIC CENTER BLVD FL 4
PHILADELPHIA, PA 19104 - Phone
- (215) 349-8222
Quick Facts
- NPI
- 1225042252
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile